Company
Nereid Therapeutics
Translating the therapeutic promise of biomolecular condensates
Also known as Nereid Therapeutics, Inc.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Nereid Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Nereid marries soft matter physics to cell biology to pioneer a new way to fight intractable diseases— cancers, neurodegenerative illnesses, and inflammatory disorders, among others.
Funding snapshot
- Total raised
- $50MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series A, $50M
Funding rounds
- Series A
- $50MCompany stated
Loading relationship preview